FDA Approves New Mucinex 12HR Cold & Fever Multi-Symptom Medication

The U.S. FDA has approved Reckitt's Mucinex 12HR Cold & Fever Multi-Symptom, marking the first over-the-counter innovation in the cold and flu category in 14 years. This new bi-layer tablet combines guaifenesin, dextromethorphan HBr, and naproxen sodium, providing 12-hour relief for common symptoms like fever, cough, chest congestion, and body pain.